Post by
pacer217 on Mar 17, 2021 5:00pm
Q FOUR tomorrow before sunrise!
The BEST case estimate from "experts " on CIBC post is a Break-even Q. @ .00 cents / share.
Longer term the prognosis is excellent; price guesses from $28. to above $40. within year.
Price action last two weeks suggests a "BEAT" before Thursday open.
Comment by
wannabebuffet on Mar 17, 2021 5:35pm
I was tempted to move out of my position into something else but with the predictions of the analysts I decided to stay in. It has made me a lot of money over the years so a few more to see how Vascepa plays out is a good plan. If Vascepa does as planned when rolled out in Canada I would think there would be a lot of US folks looking for a source.